Regenerex Pharma (RGPX) Return on Sales (2014 - 2020)
Regenerex Pharma (RGPX) reported Return on Sales of 1.41% for Q4 2020, down 128.0% year-over-year from 5.02% in Q1 2020, and up 25.87% quarter-over-quarter from 1.9% in Q3 2020.
Regenerex Pharma (RGPX) Return on Sales (2014 - 2020) Analysis & Trends
Regenerex Pharma (RGPX) has 3 years of Return on Sales data on file, last reported at 1.41% in Q4 2020.
- Return on Sales for Q4 2020 came in at 1.41%, down 128.0% year-over-year; the trailing twelve-month figure through Dec 2020 was 0.68% (changed N/A YoY), and the FY2020 annual result was 0.33%, changed N/A from the prior year.
- Return on Sales advanced to 1.41% in Q4 2020 per RGPX's latest filing, from 1.9% in the prior quarter.
- Over five years, Return on Sales peaked at 0.12% in Q4 2019 and troughed at 2.52% in Q2 2020.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -1.41% |
| Sep 30, 2020 | -1.90% |
| Jun 30, 2020 | -2.52% |
| Mar 31, 2020 | -0.23% |
| Dec 31, 2019 | -0.12% |
| Aug 31, 2014 | -0.06% |